The authors describe neuropsychological outcomes in people with Parkinson\u27s disease (PD) after their participation in an NIH-sponsored, randomized, controlled trial of cognitive-behavioral treatment for depression. Improvements in mood were associated with modest gains in verbal memory and executive functioning over the 10-week treatment period and accounted for greater variance in neuropsychological outcomes at the end of treatment than other known correlates of cognitive functioning in PD, such as disease severity, age, and education. Baseline working memory and executive skills were also associated with depression improvement over time
Purpose : Patients with Parkinson’s disease (PD) show inefficiencies in cognitive performance includ...
OBJECTIVE: Mild cognitive impairment (MCI) and psychiatric symptoms (anxiety, depression, and apathy...
Cognitive changes of Parkinson\u27s disease (PD) manifest earlier and are more heterogeneous than pr...
The authors describe neuropsychological outcomes in people with Parkinson\u27s disease (PD) after th...
The authors describe neuropsychological outcomes in people with Parkinson’s disease (PD) after their...
approximately 50 % of people with Parkinson’s disease (PD)1 and is a significant risk factor for cog...
This study compared the performance of Parkinson\u27s disease (PD) patients with and without depress...
Depression is associated with more rapid cognitive decline in Parkinson\u27s disease. The goal of th...
Neuropsychiatric and cognitive symptoms are common in patients with Parkinson's disease (PD) from th...
Depression is associated with more rapid cognitive decline in Parkinson’s disease (PD). The goal of ...
Parkinson’s disease (PD) is a movement disorder which is caused by a degeneration of dopamine produc...
BackgroundIn Parkinson's Disease (PD), cognitive dysfunctions which can reduce patients' quality of ...
Parkinson’s disease (PD) is clinically manifested by motor and non-motor symptoms, including neurops...
Depression is found in about 30%-40% of all patients with Parkinson\u27s disease (PD), but only a sm...
The aim of this study was to assess the cognitive decline in patients with Parkinson’s disease and t...
Purpose : Patients with Parkinson’s disease (PD) show inefficiencies in cognitive performance includ...
OBJECTIVE: Mild cognitive impairment (MCI) and psychiatric symptoms (anxiety, depression, and apathy...
Cognitive changes of Parkinson\u27s disease (PD) manifest earlier and are more heterogeneous than pr...
The authors describe neuropsychological outcomes in people with Parkinson\u27s disease (PD) after th...
The authors describe neuropsychological outcomes in people with Parkinson’s disease (PD) after their...
approximately 50 % of people with Parkinson’s disease (PD)1 and is a significant risk factor for cog...
This study compared the performance of Parkinson\u27s disease (PD) patients with and without depress...
Depression is associated with more rapid cognitive decline in Parkinson\u27s disease. The goal of th...
Neuropsychiatric and cognitive symptoms are common in patients with Parkinson's disease (PD) from th...
Depression is associated with more rapid cognitive decline in Parkinson’s disease (PD). The goal of ...
Parkinson’s disease (PD) is a movement disorder which is caused by a degeneration of dopamine produc...
BackgroundIn Parkinson's Disease (PD), cognitive dysfunctions which can reduce patients' quality of ...
Parkinson’s disease (PD) is clinically manifested by motor and non-motor symptoms, including neurops...
Depression is found in about 30%-40% of all patients with Parkinson\u27s disease (PD), but only a sm...
The aim of this study was to assess the cognitive decline in patients with Parkinson’s disease and t...
Purpose : Patients with Parkinson’s disease (PD) show inefficiencies in cognitive performance includ...
OBJECTIVE: Mild cognitive impairment (MCI) and psychiatric symptoms (anxiety, depression, and apathy...
Cognitive changes of Parkinson\u27s disease (PD) manifest earlier and are more heterogeneous than pr...